Detalhe da pesquisa
1.
Undeclared pre-exposure or post-exposure prophylaxis (PrEP/PEP) use among syphilis-positive blood donors, England, 2020 to 2021.
Euro Surveill
; 28(11)2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36927721
2.
Pharmacokinetics of ß-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Clin Infect Dis
; 75(1): e525-e528, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35271729
3.
Evidence of HIV pre-exposure or post-exposure prophylaxis (PrEP/PEP) among blood donors: a pilot study, England June 2018 to July 2019.
Sex Transm Infect
; 98(2): 132-135, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33782147
4.
Infant Exposure to Dolutegravir Through Placental and Breast Milk Transfer: A Population Pharmacokinetic Analysis of DolPHIN-1.
Clin Infect Dis
; 73(5): e1200-e1207, 2021 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33346335
5.
Pharmacokinetic/pharmacodynamic investigation of raltegravir with or without lamivudine in the context of HIV-1 pre-exposure prophylaxis (PrEP).
J Antimicrob Chemother
; 76(8): 2129-2136, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33993302
6.
The development and validation of a novel LC-MS/MS method for the quantification of cenicriviroc in human plasma and cerebrospinal fluid.
Biomed Chromatogr
; 34(1): e4711, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31629375
7.
Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study).
PLoS Med
; 16(9): e1002895, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31539371
8.
Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine.
Antimicrob Agents Chemother
; 63(2)2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30420479
9.
Pharmacokinetics of dolutegravir with and without darunavir/cobicistat in healthy volunteers.
J Antimicrob Chemother
; 74(1): 149-156, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30272231
10.
Cerebrospinal fluid drug concentrations and viral suppression in HIV-1-infected patients receiving ritonavir-boosted atazanavir plus lamivudine dual antiretroviral therapy (Spanish HIV/AIDS Research Network, PreEC/RIS 39).
J Neurovirol
; 24(4): 391-397, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29542028
11.
Once-daily atazanavir/cobicistat and darunavir/cobicistat exposure over 72 h post-dose in plasma, urine and saliva: contribution to drug pharmacokinetic knowledge.
J Antimicrob Chemother
; 72(7): 2035-2041, 2017 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28407075
12.
Comparison of Dried Blood Spots Versus Conventional Plasma Collection for the Characterization of Efavirenz Pharmacokinetics in a Large-Scale Global Clinical Trial-The ENCORE1 Study.
Ther Drug Monit
; 39(6): 654-658, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28953037
13.
Removal of Dolutegravir by Hemodialysis in HIV-Infected Patients with End-Stage Renal Disease.
Antimicrob Agents Chemother
; 60(4): 2564-6, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26856824
14.
Dolutegravir and elvitegravir plasma concentrations following cessation of drug intake.
J Antimicrob Chemother
; 71(4): 1031-6, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26679246
15.
A Validated Method for Quantification of Dolutegravir Using Ultra Performance Liquid Chromatography Coupled With UV Detection.
Ther Drug Monit
; 38(3): 327-31, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26859200
16.
Breast milk pharmacokinetics of efavirenz and breastfed infants' exposure in genetically defined subgroups of mother-infant pairs: an observational study.
Clin Infect Dis
; 61(3): 453-63, 2015 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25882300
17.
Cerebrospinal fluid exposure of efavirenz and its major metabolites when dosed at 400 mg and 600 mg once daily: a randomized controlled trial.
Clin Infect Dis
; 60(7): 1026-32, 2015 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25501988
18.
Plasma Tenofovir, Emtricitabine, and Rilpivirine and Intracellular Tenofovir Diphosphate and Emtricitabine Triphosphate Pharmacokinetics following Drug Intake Cessation.
Antimicrob Agents Chemother
; 59(10): 6080-6, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26195515
19.
Development, validation and clinical application of a novel method for the quantification of efavirenz in dried breast milk spots using LC-MS/MS.
J Antimicrob Chemother
; 70(2): 555-61, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25326089
20.
Validation and clinical application of a method to quantify nevirapine in dried blood spots and dried breast-milk spots.
J Antimicrob Chemother
; 70(10): 2816-22, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26108608